Literature DB >> 23928387

The management of hypertension in pregnancy.

Andrea G Kattah1, Vesna D Garovic.   

Abstract

Hypertensive pregnancy disorders complicate 6% to 8% of pregnancies and cause significant maternal and fetal morbidity and mortality. The goal of treatment is to prevent significant cerebrovascular and cardiovascular events in the mother without compromising fetal well-being. Current guidelines differentiate between the treatment of women with acute hypertensive syndromes of pregnancy and women with preexisting chronic hypertension in pregnancy. This review will address the management of hypertension in pregnancy, review the various pharmacologic therapies, and discuss the future directions in this field.
Copyright © 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23928387      PMCID: PMC3925675          DOI: 10.1053/j.ackd.2013.01.014

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  68 in total

1.  Comparison of auscultatory and oscillometric automated blood pressure monitors in the setting of preeclampsia.

Authors:  P Natarajan; A H Shennan; J Penny; A W Halligan; M de Swiet; J Anthony
Journal:  Am J Obstet Gynecol       Date:  1999-11       Impact factor: 8.661

2.  Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis.

Authors:  P von Dadelszen; M P Ornstein; S B Bull; A G Logan; G Koren; L A Magee
Journal:  Lancet       Date:  2000-01-08       Impact factor: 79.321

Review 3.  Management of mild chronic hypertension during pregnancy: a review.

Authors:  R L Ferrer; B M Sibai; C D Mulrow; E Chiquette; K R Stevens; J Cornell
Journal:  Obstet Gynecol       Date:  2000-11       Impact factor: 7.661

4.  Twenty-four-hour automated blood pressure monitoring as a predictor of preeclampsia.

Authors:  M A Brown; L Bowyer; L McHugh; G K Davis; G J Mangos; M Jones
Journal:  Am J Obstet Gynecol       Date:  2001-09       Impact factor: 8.661

Review 5.  Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.

Authors:  E Abalos; L Duley; D W Steyn; D J Henderson-Smart
Journal:  Cochrane Database Syst Rev       Date:  2001

6.  Neurological complications associated with the pre-eclampsia/eclampsia syndrome.

Authors:  K A Okanloma; J Moodley
Journal:  Int J Gynaecol Obstet       Date:  2000-12       Impact factor: 3.561

7.  Preeclampsia: New Thoughts on an Ancient Problem.

Authors:  Phyllis August
Journal:  J Clin Hypertens (Greenwich)       Date:  2000-03       Impact factor: 3.738

8.  Microalbuminuria after pregnancy complicated by pre-eclampsia.

Authors:  J Bar; B Kaplan; C Wittenberg; A Erman; G Boner; Z Ben-Rafael; M Hod
Journal:  Nephrol Dial Transplant       Date:  1999-05       Impact factor: 5.992

9.  Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.

Authors: 
Journal:  Am J Obstet Gynecol       Date:  2000-07       Impact factor: 8.661

10.  Prepregnancy body mass index and gestational weight gain as risk factors for preeclampsia and transient hypertension.

Authors: 
Journal:  Ann Epidemiol       Date:  2000-10-01       Impact factor: 3.797

View more
  24 in total

1.  Incidence of Adverse Drug Reactions in High-Risk Pregnancy: A Prospective Cohort Study in Obstetric Intensive Care.

Authors:  Tatiana Xavier da Costa; Marta Danielle de Almeida Pimenta Cunha; Priscilla Karilline do Vale Bezerra; Francine Johansson Azeredo; Rand Randall Martins; Antonio Gouveia Oliveira
Journal:  Eur J Clin Pharmacol       Date:  2019-11-25       Impact factor: 2.953

2.  Comparison of protease and aminopeptidase activities in meconium: A pilot study.

Authors:  Ewa Skarżyńska; Paulina Wilczyńska; Bartosz Kiersztyn; Joanna Żytyńska-Daniluk; Artur Jakimiuk; Barbara Lisowska-Myjak
Journal:  Biomed Rep       Date:  2020-06-09

3.  Effect of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women.

Authors:  Gabriela Campos de Oliveira Filgueira; Osmany Alberto Silva Filgueira; Daniela Miarelli Carvalho; Maria Paula Marques; Elaine Christine Dantas Moisés; Geraldo Duarte; Vera Lucia Lanchote; Ricardo Carvalho Cavalli
Journal:  Br J Clin Pharmacol       Date:  2017-01-29       Impact factor: 4.335

Review 4.  Treating Hypertension in Pregnancy.

Authors:  Dietmar Schlembach; Volker Homuth; Ralf Dechend
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

5.  Periconceptional 1,3-butanediol supplementation suppresses the superimposed preeclampsia-like phenotype in the Dahl salt-sensitive rat.

Authors:  Jeanne A Ishimwe; Melanie B Baker; Michael R Garrett; Jennifer M Sasser
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-12-17       Impact factor: 4.733

Review 6.  The Impact of Pregnancy on Antihypertensive Drug Metabolism and Pharmacokinetics: Current Status and Future Directions.

Authors:  Ian R Mulrenin; Julian E Garcia; Muluneh M Fashe; Matthew Shane Loop; Melissa A Daubert; Rachel Peragallo Urrutia; Craig R Lee
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-11       Impact factor: 4.481

Review 7.  Resistant Hypertension in Pregnancy: How to Manage?

Authors:  Maria Rita Bortolotto; Rossana Pulcineli Vieira Francisco; Marcelo Zugaib
Journal:  Curr Hypertens Rep       Date:  2018-06-11       Impact factor: 5.369

8.  Pregnancy Complications in Women with Weight Loss Surgery Compared to a Non-Surgical Population of Women with Obesity.

Authors:  Kara M Christopher; Ahmed Abdelsalam; Louise Flick; Pamela Xaverius
Journal:  Obes Surg       Date:  2022-01-18       Impact factor: 4.129

9.  Administration of recombinant human placental growth factor decreases blood pressure in obese hypertensive pregnant rats.

Authors:  Ana C Palei; Adelene Y Tan; Woo S Joo; Paul Kussie; Christopher D Anderson; Barbara A Wilson; Frank T Spradley
Journal:  J Hypertens       Date:  2020-11       Impact factor: 4.776

10.  In-vitro study of the effect of anti-hypertensive drugs on placental hormones and angiogenic proteins synthesis in pre-eclampsia.

Authors:  Subrata Gangooly; Shanthi Muttukrishna; Eric Jauniaux
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.